Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

InMed Pharmaceuticals (INM) Asset Utilization Ratio: 2022-2025

Historic Asset Utilization Ratio for InMed Pharmaceuticals (INM) over the last 3 years, with Sep 2025 value amounting to 0.33.

  • InMed Pharmaceuticals' Asset Utilization Ratio fell 25.51% to 0.33 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.33, marking a year-over-year decrease of 25.51%. This contributed to the annual value of 0.36 for FY2025, which is 1.72% up from last year.
  • According to the latest figures from Q3 2025, InMed Pharmaceuticals' Asset Utilization Ratio is 0.33, which was down 16.61% from 0.40 recorded in Q2 2025.
  • InMed Pharmaceuticals' 5-year Asset Utilization Ratio high stood at 0.55 for Q1 2025, and its period low was 0.10 during Q4 2022.
  • For the 3-year period, InMed Pharmaceuticals' Asset Utilization Ratio averaged around 0.38, with its median value being 0.39 (2024).
  • As far as peak fluctuations go, InMed Pharmaceuticals' Asset Utilization Ratio skyrocketed by 308.98% in 2023, and later decreased by 25.51% in 2025.
  • Over the past 4 years, InMed Pharmaceuticals' Asset Utilization Ratio (Quarterly) stood at 0.10 in 2022, then surged by 308.98% to 0.42 in 2023, then increased by 21.52% to 0.51 in 2024, then declined by 25.51% to 0.33 in 2025.
  • Its Asset Utilization Ratio stands at 0.33 for Q3 2025, versus 0.40 for Q2 2025 and 0.55 for Q1 2025.